Ethics of Cell and Gene Therapy (ECGT) Committee


The ISCT Committee on the Ethics of Cell and Gene Therapy (ECGT) strives to:

Identify key aspects of unproven cellular interventions in order to promote and share effective strategies between scientific/medical societies, health-care stakeholders, patient associations, and individuals, promoting the role of rigorous research and appropriate investigation and application of cell based therapies.

Learn more about Committee Resources - Click here to view

Formerly known as the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapies (PTF).

Committee Chair:

Bruce Levine
University of Pennsylvania School of Medicine
United States

Committee Vice Chairs:

Vice - Chair, Science
University of Vermont
United States
Vice - Chair, Regulatory
Baylor College of Medicine
United States
Vice - Chair, Bioethics
Georgia Institute of Technology
United States
Vice - Chair, Industry
Kiji Therapeutics


ISCT ECGT Committee Website

The ISCT ECGT Committee website contains numerous resources that strive to characterize unproven and unethical cell and gene interventions, and promote safe and effective practices worldwide.